Gross Profit for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current gross profit (TTM) is $3.29B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$3.29B
YoY change
+15.1%
5Y CAGR
+12.2%
Peak year (2025)
$3.05B
Cumulative gross profit
$26.96B
Gross Profit history chart for ResMed (RMD) from 1993 to 2025
Gross Profit history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $3.05B | +15.1% | ||
| 2024 | $2.66B | +12.7% | ||
| 2023 | $2.36B | +16.4% | ||
| 2022 | $2.02B | +10.1% | ||
| 2021 | $1.84B | +7.1% | ||
| 2020 | $1.72B | +11.8% | ||
| 2019 | $1.54B | +12.8% | ||
| 2018 | $1.36B | +13.3% | ||
| 2017 | $1.20B | +12.7% | ||
| 2016 | $1.07B | +5.4% | ||
| 2015 | $1.01B | +2.2% | ||
| 2014 | $989.79M | +5.2% | ||
| 2013 | $940.66M | +14.6% | ||
| 2012 | $820.74M | +10.7% | ||
| 2011 | $741.33M | +13.1% | ||
| 2010 | $655.48M | +18.4% | ||
| 2009 | $553.80M | +12.2% | ||
| 2008 | $493.75M | +28.4% | ||
| 2007 | $384.49M | +2.0% | ||
| 2006 | $376.89M | +37.1% | ||
| 2005 | $274.86M | +26.8% | ||
| 2004 | $216.74M | +25.2% | ||
| 2003 | $173.09M | +29.9% | ||
| 2002 | $133.25M | +27.2% | ||
| 2001 | $104.78M | +23.5% | ||
| 2000 | $84.87M | +33.0% | ||
| 1999 | $63.80M | +35.5% | ||
| 1998 | $47.10M | +49.5% | ||
| 1997 | $31.50M | +66.7% | ||
| 1996 | $18.90M | +47.7% | ||
| 1995 | $12.80M | +60.0% | ||
| 1994 | $8.00M | +66.7% | ||
| 1993 | $4.80M | — |
Gross Profit values are taken from ResMed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of ResMed (RMD) gross profit is $3.05B – grew 15.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed gross profit compounded at +12.2% per year, sustaining 32 straight years of year-over-year growth.
$3.05B stands as the all-time-high annual gross profit, posted in 2025, against a low of $4.80M during 1993.
Among 8 Healthcare peers, ResMed (RMD) ranks 9th; the peer median for gross profit is $53.80B.
ResMed Gross Profit by Year
ResMed Gross Profit 2025: $3.05B
ResMed gross profit in 2025 was $3.05B, grew 15.1% from 2024. This figure represents the highest annual value in the available history.
ResMed Gross Profit 2024: $2.66B
ResMed gross profit in 2024 was $2.66B, grew 12.7% from 2023.
ResMed Gross Profit 2023: $2.36B
ResMed gross profit in 2023 was $2.36B, grew 16.4% from 2022.
ResMed Gross Profit 2022: $2.02B
ResMed gross profit in 2022 was $2.02B, grew 10.1% from 2021.
ResMed Gross Profit 2021: $1.84B
ResMed gross profit in 2021 was $1.84B.
See more financial history for ResMed (RMD).
Sector peers — Gross Profit
Companies in the same sector as ResMed, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is ResMed's gross profit?
- Latest reported gross profit for ResMed (RMD) is $3.29B (period ending December 31, 2025).
How has ResMed gross profit changed year-over-year?
- ResMed (RMD) gross profit changed +15.1% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed gross profit?
- ResMed (RMD) gross profit compound annual growth rate is +12.2% over the most recent 5 years available.
When did ResMed gross profit hit its highest annual value?
- ResMed gross profit reached its highest annual value of $3.05B in 2025.
What was ResMed gross profit in 2024?
- ResMed (RMD) gross profit in 2024 was $2.66B.
What was ResMed gross profit in 2025?
- ResMed (RMD) gross profit in 2025 was $3.05B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.